VACCINE TECHNOLOGIES TO ADVANCE NEXT GENERATION ANTHRAX VACCINES

该合同支持的产品开发活动可能跨越通过临床研究进行的制造和配方过程开发，包括：生产、表征和发布中试批次的cGMP材料；疫苗稳定性测试；进行非临床研究，例如支持新药研究的毒理学研究；以及支持产品开发所需的所有分析和试剂的开发、鉴定和验证(如有必要)。

This contract supports product development activities that may span manufacturing and formulation process development through clinical studies, including: manufacturing, characterization and release of pilot lot cGMP material; vaccine stability testing; conduct of non-clinical studies, e.g., Investigational New Drug (IND)-enabling toxicology studies; and development, qualification and, where necessary, validation of all assays and reagents needed to support product development.